Six Summer Hair Care tips from @HAIRLINECLINIC

1. Start summer with a trim. You'll get rid of split ends and refresh your style. You might need a mid-season cut, too. Hair really does grow faster in the summer. That's because there are more hairs in the anagen, or growing, stage during late spring and summer than in the dead of winter.

2.Shield your strands from the sun. Make a daily habit of applying a hair care product that contains UV filters (these can be in spray, gel, or cream formulas). These products protect hair from sun damage and help keep color-processed hair from fading. If you'll be spending lots of time outdoors, wear a wide-brimmed hat. Not only will it keep your strands from getting scorched, it will also protect your scalp and ears, areas that are vulnerable to skin cancer.

Six Summer Hair Care tips from @HAIRLINECLINIC pic.twitter.com/NnYVip5cOQ

— Press Release Watch (@PrReleaseWatch) April 14, 2018

3.Saturate strands before taking a dip. If your hair is drenched with clean water or leave-in conditioner, it won't absorb as much saltwater or pool chemicals. It's also a good idea to try to rinse your hair after a swim. If there isn't a shower nearby, keep a spray bottle filled with fresh water.

4.Switch to a moisturizing shampoo and conditioner. You may be washing your hair more frequently to deal with summer's sweat and grime. Use a clarifying, or anti-residue, shampoo once a week to clear away product buildup and chemicals. Just be sure to follow with a deep-conditioning treatment.

5.Skip the hot tools. At least once or twice a week, give your hair a break from blow dryers, flat irons, and curling irons. wash your hair at night and piling it up in a bun, a braid, or ponytail before you head to bed. "When you wake up, you'll have a nice beachy wave. It's the perfect look for weekends, or make it work-ready with accessories like a thin headband or pretty barrettes.

6.Outwit frizz. Hair that's healthy and well-maintained is your best defense against frizz. Along with regular trims and conditioning, a drop or two of an anti-frizz oil or serum can help smooth hair and add shine.

#NGOs offer free palliative care to terminally ill #Cancer patient across east and north east Bangalore

Bangalore Hospice Trust – Karunashraya & Sri Chandanmal Pukhraj Bothra Medical Centre have extended free palliative care to terminally ill cancer patients across east and north east Bangalore.With a view to alleviate the extreme suffering of the patients of advanced cancer and to make medical consultation easily accessible to patients in east and north east Bangalore, there is a plan to start a clinical OPD for Cancer patients for symptom management and pain relief at Bothra Trust premises once a week,said Dr. Veena of  Sri Chandanmal Pukhraj Bothra Medical Centre at a press meet in Bengaluru today.

Bangalore Hospice Trust – Karunashraya & Sri Chandanmal Pukhraj Bothra Medical Centre extent free palliative care to terminally ill #Cancer patient across east and north east Bangalore @IAPCpage pic.twitter.com/1TVV73CudW

— Press Release Watch (@PrReleaseWatch) April 12, 2018

In the last 22 years, through the Home care services Bangalore Hospice Trust  have cared for around 4051 patients.A dedicated multi-disciplinary team comprising of a Doctor, nurses, counsellors, and social workers, visit the homes of patients and families in and around Bangalore and provide palliative care. Currently, home-care services are provided five days in the week and depending on need, each patient is visited once or twice a week said Dr. S. N. Simha from Bangalore Hospice Trust.
Bangalore Hospice Trust – Karunashraya – was set up in 1994 as a Public Charitable Trust jointly by the Indian Cancer Society (Karnataka chapter) and Rotary Club of Bangalore, Indiranagar. Its aim is to provide free palliative care for advanced stage cancer patients.On the other hand Sri Chandanmal Pukraj Bothra Trust has been serving the needy from the last 18 years, with over 20,000 patients visiting regularly and availing the best medical facilities totally free of cost.The Trust also offers regular clinics for Diabetes, hypertension and cardiac care, eye care, ENT orthopedics, pediatrics etc., with experts offering their consultation.

#BloodMatters @TwitterIndia with @BloodDonorsIn launch blood donation drive in #Bengaluru

As part of its 12th birthday celebrations @TwitterIndia launches  #BloodMatters with @BloodDonorsIn in #Bangalore with the support of @MoHFW_INDIA and @JPNadda to boost blood donation drive in India. pic.twitter.com/zplYuOnmUu

— Press Release Watch (@PrReleaseWatch) March 20, 2018

People can request for blood donation simply with a Tweet to @BloodDonorsIN with their location hashtag, blood type, mobile contact and Twitter handle. People interested to help can follow @BloodDonorsIN and respond or retweet requests for help. Twitter will be supporting the implementation of an automated response solution to scale the operations of @BloodDonorsIN, currently run by a group of volunteers. Twitter will also amplify the real-time communication efforts of the handle with verification, promotion on Twitter, and use Twitter Lite to connect @BloodDonorsIN with people across the entire country, from the metros to rural India.

#BloodMatters @TwitterIndia with @BloodDonorsIn launch blood donation drive in #Bengaluru pic.twitter.com/OeX5se9jkh

— Press Release Watch (@PrReleaseWatch) March 21, 2018

Human Assisted Robotic Hair Transplant done at @HAIRLINECLINIC Centre in Jaynagar Bengaluru

First Human Assisted #Robotic Hair Transplant done at @HAIRLINECLINIC Centre in Jaynagar #Bengaluru today pic.twitter.com/nAJqyA1e8Z

— Press Release Watch (@PrReleaseWatch) August 3, 2017

Speaking on introducing Robotic Hair Transplant at Hairline International, Dr. Bani Anand, Founder and Managing Director, Hairline International Hair and Skin Clinic says, “We have seen that patients want procedures that are quick, minimally painful and non invasive which yield the best results. Robotic Hair Transplant ensures high levels of accuracy and results. In fact, considering the reduced number of personnel required to complete the procedure, the patient is much more at ease as well. The system also comes with an integrated cloud data management system which makes programing of depth for extraction and implantation easy and accurate”.
Robotic Hair Transplant ensures that the infection rate and bleeding is minimal as the procedure is extremely accurate in terms of depth and breadth of extraction or implantation of the hair. In fact, depth control can be pre-fixed using a calibrated computerized approach. The procedure ensures that there is minimal exposure of hair follicles to an external environment reducing dessication and depth the follicles and thus enhancing the results of a hair transplant.

Medical startup @PrimecareBlr celebrated 100th baby birth at Embrace in Frazer Town #Bengaluru

 

.@PrimecareBlr celebrated the 100th baby birth at Embrace in Frazer Town #Bengaluru pic.twitter.com/JRDZ8iGrGx

— Press Release Watch (@PrReleaseWatch) July 11, 2017

Speaking on the occasion, Dr. Syed Naveed Azam, Group Medical Director said, “Our team of doctors, clinical staff and non-clinical staff couldn’t be happier with the progress Embrace by PRIMECARE has made since first opening its doors in January 2017. The fact that we have more than 250 families we are taking care of at present, is a testimony to our commitment of providing quality healthcare clubbed with best supporting infrastructure and services.”

.@Omega_HMS to hire 1000 people in Bengaluru in next 6 months

Commenting on this, Gopi Natarajan, Co-Founder and CEO, Omega Healthcare, said, “Our business has been expanding both horizontally and vertically as a result of which we have been hiring continuously for the various services we provide. Today we have over 4,000 employees working in the Bengaluru facility alone and have been growing at a CAGR of about 30 percent. This gives us more opportunities to rapidly scale hiring of talented young professionals.”
 

.@Omega_HMS  to hire 1000 people in Bengaluru in next 6 months; currently it has more than 12,000 employees globally pic.twitter.com/aiPgB3Lr8Q

— Press Release Watch (@PrReleaseWatch) July 9, 2017

SV Krishnan, Chief Operating Officer, Omega Healthcare, said, “This is a great moment for us to cherish and we look forward to adding many such feathers to our cap. Truly our people are the reason behind our success!”

Julius Raj Stephen - Joint Head of Operations and Location Head - Bengaluru, Omega Healthcare, said, “We have been able to provide alternate career options to life sciences graduates by training and providing them the required skills. Through the Omega Medical Coding Academy (OMCA) we aspire to train more people in medical coding and give them a platform to grow in this field.”

Omega Healthcare currently serves over 100 clients in the US. With the recent acquisition of WhiteSpace Healthcare, the company has expanded its offerings to include cloud-based data analytic solutions.

Private Hospitals across #Karnataka not to admit patients under 3 State Govt. subsidised schemes w.e.f. 16th Jan.

Federation of Healthcare Associations (FHA), a newly formed consortium of Registered Private Hospital Associations in Karnataka have decided to stop serving patients under the following schemes (Vajpayee Arogya Shree Scheme or VAS,Rajiv Arogya Bhagya Scheme or RAB,Jyothi Sanjeevini Scheme or JSS) with effect from 16th Jan 2017.

Private Hospitals across #Karnataka not to admit patients under 3 State Govt. subsidised schemes w.e.f. 16th Jan. pic.twitter.com/gtYb3wncCx

— Press Release Watch (@PrReleaseWatch) January 9, 2017

In press statement made by FHA said, 'No timely payment to hospitals for the services rendered to the scheme patients. Not honoring the payment terms as per the contractual terms which is forcing hospitals to stop these schemes till it is completely addressed. We have to wait months together for our payment and are faced with challenge of paying our suppliers, staff and other agencies.'

FHA claims Government or Suvarna Arogya Suraksha Trust (SAST) has not responded for making prompt payment and not honoring the contract terms FHA has decided not to admit new patients under 3 State Govt. subsidised schemes w.e.f. 16th Jan.Suvarna Arogya Suraksha Trust was constituted on 20th February 2009 vide Government Order No: HFW 216 CGE 2008 Bangalore.

FHA claims payment of Rs.110 cr.is pending under these schemes and bogus BPL card holders are taking away the benefits meant for poor people.

Robot assisted Kidney Transplant by @ManipalHealth

Explaining the procedure for this surgery Dr. Deepak Dubey, Consultant Urology & Renal Transplant , Manipal Hospitals who conducted the surgery successfully said, “Robotic surgery is 100% accurate and safe. The surgeon thus can operate with enhanced precision, dexterity and control even during the most complex procedures. The benefits of this surgery are immense as there are fewer complications such as surgical site infection, lesser pain and blood loss, quicker recovery and smaller scars. The patient and the donor are doing very well and have recovered completely.”
 

Manipal Hospitals performs robot assisted Kidney Transplant pic.twitter.com/hSZQWQTAQs

— Press Release Watch (@PrReleaseWatch) December 21, 2016

A small cut was made around the umbilicus and kidney was inserted into the recipient’s body. The blood vessels of the kidney were sutured to the blood vessels of the recipient using the Robot. Robotic instruments have 360 degree rotation compared to the human wrist which has only 270 degree rotation and provides the surgeon with a 10x magnified, high-definition, 3D-image of the body's intricate anatomy using key-hole technique. Complete rehearsal was done a day prior to the procedure and the patient and family were given all the relevant information.

Speaking on the occasion Dr. Sudarshan Ballal, Chairman, Manipal Hospitals said, “Reasonable costs, less pain, minimal invasion, early recovery and increasing awareness have put India on the global map when it comes to robot-assisted surgeries across the health spectrum and the country is poised to take a leap soon. Robotic procedures have started to cover a wide spectrum of procedures —cardiac, urology, general surgery, thoracic, gynaecology, head and neck, vascular, paediatrics etc.”

Hope for 15 million blinds in India

Now blinds can see!!! Sounds unbelievable, isn't it! Hold your breath. She was totally blind for seven years. But now she could see some coloured flashes. Thanks to a miracle visual stimulator chip that changed her life once and for all. This miracle chip (also called bionic eye) is a retinal implant. And it could restore sight to millions.

A 30-year- old white woman lost her sight eight years ago due to a rare disease which attacks the pigment in the eyes. Within a year she was completely blind.Her world turned dark and colourless.
The blind lady saw some coloured flashes, lines and spots when a stimulator chip was inserted into her brain and signals were sent from a computer.
The moment she saw colour for the first time was a veryemotional experience. It touched us all very deeply as human being, said Dr Nader Pouratian, who performed the operation on her.

North Carolina’s 66-year old blind man Larry Hester got his vision after 33 years of blindness. Larry Hester was diagnosed with retinitis pigmentosa when he was in his early 30s.

On October 1, 2014, Hester became only the seventh person in the US to have a so-called bionic eye - an Argus II Retinal Prosthesis Device.
Hester's wife, Jerry, said her most cherished moment in life came while they were watching a football game. She was sitting in a dark chair, and her skin was enough of a contrast that Hester could see flashes. He reached out and touched her face.

Doctors at the University of California Los Angeles are on the brink of a breakthrough innovation. They are waiting for the permission from US regulators to connect the simulator chip to a camera.

They are hoping to send moving images directly to the brain from the camera mounted on a pair of glasses worn by patient. They will try to send video signals from a system called the Orion I, which captures images in front of the eye of the patient.

The bionic eye system consists of a small digital camera, external processor and an implant with a microchip and stimulating electrodes surgically placed in the back of the eye of the patient.

The movement of bionic eye quite similar to a healthy eye through eye-tracking software within the glasses to detect movement and then adjust the bionic eye.

In a bionic eye system images are converted into electrical pulses and transmitted wirelessly to an array of electrodes attached to the retina. The electrodes stimulate the remaining retina's remaining cells which send the information to the brain.

Bionic eye incorporates technology initially developed by researchers at the Duke Eye Centre; its sophisticated features were further enhanced and marketed by a company called Second Sight Medical Products in USA.
This bionic eye could a big boon for India as well. By a conservative estimates of the Union Health Ministry, of the 37 million people who are blind in the world, more than 10 million are in India. Most of them lose vision with diseases of the retina like macular degeneration.
Every year from the 1st to 7th April to we observe Prevention of Blindness Week to increase awareness about blindness.
Dr Rajat N Agarwal, a scientist of Indian origin at the University of Southern California, made the first bionic eye device in April, 2011.
Bionic eye system has the potential to restore vision to patients blinded due to virtually any reason, including glaucoma, cancer, diabetic retinopathy, or trauma.
Bionic eye has not yet been used on Indian patients mainly because of its high costs; Here in India the device alone costs around Rs 22 lakhs, minus the hospital and surgical costs. Till date only 100 people across the globe have so far got the Bionic Eye implant till date.

Hair dye patch test for allergic reactions @HAIRLINECLINIC

Hairline International Hair and Skin Clinic is offering allergy testing service that will pre-determine if you are prone to an allergy to retail hair dyes available in the market and their contents.

Hair dye patch test for allergic reactions @HAIRLINECLINIC pic.twitter.com/rYINim30MG

— Press Release Watch (@PrReleaseWatch) October 14, 2016

Speaking on the introduction of this allergy test, Dr. Premalatha, Dermatosurgeon, Hairline International says, “Most people who use hair dye complain of hair loss, though most are not aware that this could be caused by their dyes. Chronic allergies occur in the form of hair loss or pigmentation of the forehead or along the crown. An acute allergy is when a patient notices excessive itching on the scalp, and pimple-like lesions on the scalp and forehead and around the areas of application. In some cases it can be life-threatening where it can affect the eye lids, causing them to swell, or cause suffocation (Angio Edema)”.

India's Biosimilars market is expected to cross $40 Billion by 2030

Biosimilars presents a $240 Billion global opportunity for Indian Pharmaceuticals Industry while domestic market is expected to cross $40 Billion by 2030 ” says ASSOCHAM-SATHGURU Report released by Prof. D. Swaminadhan, President & Director General, Jawaharlal Nehru Institute of Advanced Studies (JNIAS) at ASSOCHAM-Department of Pharmaceuticals Conference on BioPharma at Hyderabad
 

India's Biosimilars market is expected to cross $40 Billion by 2030 pic.twitter.com/bq0xOU3pvd

— Press Release Watch (@PrReleaseWatch) October 8, 2016

Indian Biosimilars industry is close to $ 300 Million in 2015. Domestic sales are close to $ 250 Million growing at CAGR of 14% while, exports contributed close to $ 51 Million. However, with the introduction of a new regulatory policy in India and increased affordability that Biosimilars offer, the domestic market is expected to grow at an accelerated pace and reach the target of $40 Billion by 2030 & will command ~20% share in global market says ASSOCHAM-SATHGURU Report released during ASSOCHAM and Department of Pharmaceuticals, Government of India Conference on “BioPharma: Biosimilars and Biogenerics; Emerging Investment Destination” at Hyderabad.

Heler skin hair and lifestyle clinic launched in #Bengaluru ; focuses on Non-Surgical procedures using Lasers

Heler skin hair and lifestyle clinic launched in #Bengaluru ; focuses on Non-Surgical procedures using Lasers pic.twitter.com/FXyYF1iNZf

— Press Release Watch (@PrReleaseWatch) October 4, 2016

The clinic offers a complete array of Dermatology Medical Aesthetics and Lifestyle procedures and focuses on Non-Surgical procedures ranging from routine peels to comprehensive laser treatments.
'All our services and procedures are delivered by highly experienced professionals-including Dermatologists, Internal Medicine Specialists, Gynecologists, Urologist, Nurses and trained Aestheticians,' said Dr Asif Sheik, Founder- Heler Skin Hair & Lifestyle Clinic.

#Bangalore based MedGenome Labs brings Non-invasive prenatal screening test (NIPT) for pregnant women

“We believe that tests such as NIPT can change the way the invasive procedures on pregnancies are administered in our country, providing the obstetrician, pregnant women and her family with insights to make informed decisions and manage the baby’s health better” said Sam Santhosh, Chairman MedGenom.

#Bangalore based MedGenome Labs brings Non-invasive prenatal screening test (NIPT) for pregnant women pic.twitter.com/HBBiFGTc2d

— Press Release Watch (@PrReleaseWatch) September 6, 2016

Bangalore based MedGenome a provider of genomics research services globally had received $20 million Series B investment from Sequoia Capital last year.MedGenome is a pioneer in introducing genomic technologies in India.According to MedGenome the preliminary reports on Non-invasive prenatal screening test (NIPT) on Indian population does strongly suggest that it helps obstetricians and pregnant women across age groups to better manage their pregnancy at a very early stage.

Initiative to raise awareness on Head and Neck Cancer by Healthcare Global Enterprises Ltd. (HCG)

With The International Federation of Head and Neck Oncologic Societies (IFHNOS) having proclaimed July 27th “World Head and Neck Cancer Day”, HCG along with Pink Hope Patient Support Group organized an awarness campaign on head and neck cancer.

Initiative to raise awareness on Head and Neck Cancer by Healthcare Global Enterprises Ltd. (HCG) pic.twitter.com/WXpitimwoa

— Press Release Watch (@PrReleaseWatch) July 28, 2016

“Head and neck cancer is the sixth most common cancer in the world and in India constitutes 30-40 per cent of all cancers among men. The most common causes are consumption of tobacco and alcohol. Alcohol often taken together with Cigarette makes carcinogens in tobacco enter our tissues better as alcohol is an excellent solvent.  Smokeless tobacco, such as gutka or paan, is a major issue in India. These agents, when taken together, increase the person’s cancer risk by eight or 10 times, accounting for 90 percent of oral cancers and 80 percent of laryngeal cancers in our population. We are the mouth cancer capital of the world owing to this habit. An emerging problem today is human papilloma virus in head and neck cancer, especially tonsil. HPv was known to cause cervical cancer, but today even Tonsillar Cancers are increasing due to HPv infection,” said Dr. Vishal Rao – Consultant - Head and Neck Surgeon - HCG

Thyrocare lists at Rs 662 over the #IPO price of Rs 446

Diagnostic chain operator Thyrocare Technologies has made a spectacular debut in stock markets today, rising as much as 49 per cent to Rs 665 on the National Stock Exchange. The diagnostic chain operator had issued shares at Rs 446 in its initial public offer (IPO), which closed on April 29th.
Thyrocare Technologies Ltd. is a healthcare service provider. It owns and operates chain of clinical diagnostic centres in India. It offers testing services, disorder testing, and report tracking services. The firm offers its services to corporate houses, hospitals laboratories and doctors. The company was incorporated in 2000 and is based in Mumbai, Maharashtra with additional offices in Bahrain, Nepal and Bangladesh.

EXCL A Velumani, Chairman, MD, Thyrocare: Expect sales growth of over 35% in the next 3-4 years. https://t.co/H90MW48f1R

— CNBC-TV18 News (@CNBCTV18News) May 9, 2016

Thyrocare CEO A Velumani has told a leading bisiness channel today that the company wants to open 20 more testing labs across the country in next 2 years with an invest of Rs.3-4 crore per lab.

New ‘Blood Banking App' by Indian Red Cross Society to tackle blood shortage in India #RedCrossDay

India has a recorded shortage of 3 million units of blood, and every two seconds, someone needs blood. Moreover, blood banks rely heavily on replacement donors due to the lack of required numbers of voluntary donors to maintain stock. The app caters to billions of people who face difficulties looking out for blood donors during an emergency medical situation.
The app will initially be tested in India and will be rolled out in the rest of the world. The app will is on both iOS and Android platforms and users will be able to make appointments through the app round the clock. http://www.bloodbanking.org.

More than 15% expectant mums in #B'luru are #Diabetic

A recent study in Bengaluru by the Asian Research and Training Institute for Skill Transfer (ARTIST) found more than 15% of pregnant women affected by gestational diabetes mellitus (GDM), even without a diabetic family history in case of some patients.

More than 15% expectant mums in #B'luru are #Diabetic pic.twitter.com/7TOMDXKlxU

— Press Release Watch (@PrReleaseWatch) May 6, 2016

'This pregnancy-induced diabetes is seen more in urban areas compared to rural areas,' said Dr Shubha Rama Rao, head of OBG department at St Martha's Hospital. She sees at least 20 to 25 expecting mothers with gestational diabetes out of the 250 patients who visit her every week. Another 25% are inflicted with known diabetes, she added.

It mostly happens due to undisciplined lifestyle, improper diet and lack of exercise before and during pregnancy.

Dr Vidya Desai Mohan, senior gynaecologist at Manipal Hospitals, said, "The hormonal changes in the body make pregnant women easily get diabetes. Women who have the tendency to get diabetes or who are in the borderline will get diabetes easily at this juncture. If they don't change their lifestyle, particularly their diet, it may become uncontrolled. In the last decade there has been a significant increase in the cases of pregnancy induced diabetes."

New immunotherapy trial holds the key for curing type 1 #diabetes

India is home to over 61 million diabetic patients.By 2030, India's diabetes burden is expected to cross the 100 million mark.And by 2040 there will be more than 140 million people likely to be suffering from diabetes in South-east Asia, according to International Diabetes Federation (IDF).

415M adults have #diabetes. By 2040 this will rise to 642M. https://t.co/vtePIOXLWA @IntDiabetesFed #DiabetesAtlas pic.twitter.com/I7JPUolZv5

— Int. Diabetes Fed. (@IntDiabetesFed) February 8, 2016

The search for a treatment for Type 1 diabetes (T1D) International Diabetes Federation's (IDF) will be stepped up with the start of a new phase one clinical trial at Guy’s Hospital in London.
The new immunotherapy treatment, called MultiPepT1De, is being developed to target the autoimmune attack that leads to the development of Type 1 diabetes.
Type 1 diabetes is an autoimmune disease in which cells in the pancreas that make insulin are killed by the immune system. The new therapy, MultiPepT1De, will use fragments of proteins, known as peptides, in an effort to stop this process by ‘switching off’ the specific autoimmune attack, and hopefully preventing further destruction of the pancreatic cells.
In laboratory testing, MultiPepT1De is more powerful than the first generation treatment trialled last year and is designed to benefit a higher proportion of those with Type 1 diabetes than its predecessor.
MultiPepT1De was developed with funding from the Wellcome Trust by researchers at King’s College London working in the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Guy’s and St Thomas’ and King’s College London.
MultiPepT1De will be trialled on 24 people with Type 1 diabetes by autumn 2016 and the study team is hopeful of positive results that build upon their previous findings showing that the first generation of MultiPepT1De, called MonoPepT1De, is safe and well tolerated, with some evidence of positive effects in T1D patients.
Professor Mark Peakman, Principal Investigator at the BRC and Head of the Division of Diabetes and Nutritional Sciences at King's, said: “We are really looking forward to seeing the results from this new trial. What we are doing is a big step forward in precision medicine, taking a set of patients with a particular disease and genetic background and giving them an immunotherapy designed in the laboratory specifically for them. Obviously we will need to wait until we have the full results of the trial before we know if it is successful but at this stage we are hopeful.”
Dr Stephen Caddick, Director of Innovations at the Wellcome Trust, said: “Type 1 diabetes is a very serious condition that normally requires lifelong treatment with insulin therapy, but this promising new form of ‘immunotherapy’ could be set to change that. By retraining the immune system to prevent it from attacking insulin-producing cells, it may be possible to slow progression of the disease or even stop it in its tracks. If this approach is proved successful in larger studies it has the potential to transform the lives of people with Type 1 diabetes.”
In the last decade, the number of people in the UK with diabetes has risen by around 65 per cent to 4m, according to Diabetes UK, with around 400,000 adults and children now suffering from Type 1 diabetes. Treating diabetes is estimated to cost the NHS around £10 billion per year.
MultiPepT1De is based on an area of study called peptide immunotherapy, which is currently being applied to a number of other diseases, including allergies and multiple sclerosis.

Mrs India @shilpareddy217 flagged off ‘Glaucoma Awareness Walk’ in #Hyderabad today

Currently, in India, every 8th individual or nearly 40 million aged 40 years or older either has glaucoma or is at risk of developing the disease. 11.2 million Indians suffer from the disease with 1.1 million blind, including children. Glaucoma more commonly affects people beyond the age of 40 years. High myopes, diabetics and those with a positive family history have higher risk of developing glaucoma. Screening family members of patients with glaucoma is mandatory, as this disease can affect siblings and children of patients with glaucoma in up to 10‐20% of cases.

Mrs India @shilpareddy217 flagged off ‘Glaucoma Awareness Walk’ in #Hyderabad today pic.twitter.com/ymGT58oPVA

— Press Release Watch (@PrReleaseWatch) March 6, 2016

61 million persons worldwide have glaucoma and that is expected to rise to almost 80 million by the year 2020. Blindness from glaucoma is 80% preventable, yet almost 7 million people are blind from glaucoma in the world, and 2/3 of the world's blind and visually impaired are women. Ninety percent of Glaucoma in the country is undetected, mostly due to lack of awareness.
‘Glaucoma Awareness Walk’ was organised by L. V. Prasad Eye Institute (LVPEI) on Sunday at Jubilee Hills in Hyderabad

Free #meditation camp for children

Free #meditation camp for children pic.twitter.com/qeDg9yWTTp

— Press Release Watch (@PrReleaseWatch) February 15, 2016

To register for Anapana meditation camp, students can call on 080 26391509 

When: 21st February 2016

Time: 10 AM to 4 PM

Where: Jnana Vijnana Vidyapeetha, 11th Main, 6th Cross, R.K. Layout,Padmanabhanagar,, Bengaluru, Karnataka 560070